Preparation method of 2-hydroxy-3′-nitro-biphenyl-3-carboxylic acid_Kain Industrial Additive

Background and overview[1] Eltrombopag (trade name: Promacta) was developed by the British company GlaxoSmithKline. It was approved by the FDA for marketing in the United States in November 2008. It i…